Corpus ID: 170077256

THE CLINICAL AND RADIOLOGICAL INVESTIGATION OF TWO CASES WITH NEUROTOXICITY FOLOWING METHOTREXATE TREATMENT

@inproceedings{Mine2008THECA,
  title={THE CLINICAL AND RADIOLOGICAL INVESTIGATION OF TWO CASES WITH NEUROTOXICITY FOLOWING METHOTREXATE TREATMENT},
  author={Mine and Mevl{\"u}t and A. Polat},
  year={2008}
}
  • Mine, Mevlüt, A. Polat
  • Published 2008
  • Methotrexate is a chemotherapeutic agent which is a member of antimetabolite group drugs, and used in neoplastic diseases such as acute lymphoblastic leukemia, lymphoma and osteosarcoma. Methotrexate has various side effects such as myelosuppression, mucositis, hepatic and tubular necrosis, central nervous system toxicities. In this article, clinical and radiological findings and longterm follow-up of two cases with central nervous system neurotoxicity following methotrexate treatment are… CONTINUE READING

    References

    SHOWING 1-10 OF 17 REFERENCES
    Neurotoxicity of antineoplastic drugs.
    • 232
    Neurologic sequelae of methotrexate and ionizing radiation: a new classification.
    • 276
    Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    • 250
    Transient cerebral dysfunction secondary to high-dose methotrexate.
    • 147
    Biochemical and Clinical Aspects of Methotrexate Neurotoxicity
    • 198
    Childhood leukemia: central nervous system abnormalities during and after treatment.
    • 73
    • PDF